ESLAW icon

Estrella Immunopharma, Inc. Warrant
ESLAW

11 hedge funds and large institutions have $212K invested in Estrella Immunopharma, Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 10 closing their positions.

Holders
11
Holders Change
-8
Holders Change %
-42.11%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
5
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
HCM
1
Highbridge Capital Management
New York
ASM
2
ATW SPAC Management
New York
$44K 183,099 -11,901 -6%
EFI
3
EHP Funds Inc
Canada
$41.4K 172,315
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$21K 87,500
SIA
5
SkyView Investment Advisors
New Jersey
$15K 62,500
YCM
6
Yakira Capital Management
Connecticut
$11.2K 46,485 -20,300 -30%
CAC
7
Cowen and Company
New York
$6.87K 28,597 +28,597 New
CS
8
Clear Street
New York
$6.87K 28,591 -300 -1%
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$4.58K 19,064 -59,317 -76%
MFG
10
Magnus Financial Group
New York
$3.77K 15,695 +15,695 New
LCM
11
Landscape Capital Management
New Jersey
$3.4K 13,682
RCM
12
Robinson Capital Management
Michigan
$1.75K 11,805 -11,805 -50%
BFM
13
Boothbay Fund Management
New York
-201,800 Closed
CH
14
CVI Holdings
Delaware
-86,040 Closed
Hudson Bay Capital Management
15
Hudson Bay Capital Management
Connecticut
-51,929 Closed
Citadel Advisors
16
Citadel Advisors
Florida
-50,920 Closed
RCM
17
Radcliffe Capital Management
Pennsylvania
-50,000 Closed
WA
18
Whitebox Advisors
Minnesota
-45,476 Closed
SOA
19
Sea Otter Advisors
Florida
-40,000 Closed
SSA
20
Schonfeld Strategic Advisors
New York
-19,500 Closed
Bank of America
21
Bank of America
North Carolina
-400 Closed
UBS Group
22
UBS Group
Switzerland
-200 Closed
CFGS
23
Concourse Financial Group Securities
Alabama
Citigroup
24
Citigroup
New York